Farmacijos namai - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 243,801 | 187,226 | 145,179 | 132,814 | 151,225 | 158,536 | 175,554 | 154,488 |
| Profit before tax | -20,557 | -17,157 | 162 | -29,337 | -24,561 | 13,954 | 36,928 | 14,418 |
| Net profit | -20,557 | -17,157 | 133 | -29,337 | -24,561 | 13,219 | 35,081 | 13,588 |
| Equity | -12,079 | 70,764 | 70,896 | 41,559 | 16,998 | 30,217 | 60,298 | 73,887 |
| Liabilities | 310,116 | 218,030 | 212,728 | 218,906 | 225,862 | 225,130 | 227,595 | 30,473 |
| Non-current assets | 181,239 | 151,551 | 119,192 | 89,021 | 158,266 | 152,144 | 150,378 | 51,959 |
| Current assets | 116,816 | 137,118 | 165,092 | 171,379 | 83,615 | 103,692 | 134,563 | 51,700 |
| Total assets | 298,055 | 288,669 | 284,284 | 260,400 | 241,881 | 255,836 | 284,941 | 103,659 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 45,712 | 43,125 | 65,729 |
| Social insurance contributions | - | - | - | - | - | 14,347 | 13,433 | 11,813 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +17.3% | -23.2% | -22.5% | -8.5% | +13.9% | +4.8% | +10.7% | -12.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -6.9% | -5.9% | 0.0% | -11.3% | -10.2% | 5.2% | 12.3% | 13.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | -24.2% | 0.2% | -70.6% | -144.5% | 43.7% | 58.2% | 18.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -8.4% | -9.2% | 0.1% | -22.1% | -16.2% | 8.3% | 20.0% | 8.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -8.4% | -9.2% | 0.1% | -22.1% | -16.2% | 8.8% | 21.0% | 9.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 3.1 | 3.0 | 5.3 | 13.3 | 7.5 | 3.8 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 30,796 | 26,747 | 24,197 | 21,250 | 24,523 | 26,423 | 30,980 | 38,622 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Farmacijos namai - Social security debts
The company had no debts to Sodra
Farmacijos namai - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Farmacijos namai, UAB (code 136027121) is a Private Limited Liability Company engaged in publishing of journals and periodicals. In 2025, revenue amounted to €154.5K, down 12.0% year on year and slightly below the 2023 level, while the two-year change was -2.5%. Net profit was €13.6K, compared with €35.1K in 2024 and €13.2K in 2023, so the latest year remained profitable but weaker than the prior year. The 2025 profit margin stood at 8.8%, after 20.0% in 2024 and 8.3% in 2023. The balance sheet also changed materially in 2025: equity increased to €73.9K, liabilities fell to €30.5K, and total assets decreased to €103.7K from €284.9K a year earlier. The equity ratio was 71.3% and debt-to-equity 0.41, indicating a conservative financing structure. Asset turnover reached 1.49x. Return on equity was 18.4% and return on assets 13.1%. Revenue per employee was €38.6K and profit per employee €3.4K.